XML 41 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Business Segment Information - Schedule of Business Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 02, 2024
Oct. 28, 2023
Nov. 02, 2024
Oct. 28, 2023
Feb. 03, 2024
Segment Reporting Information [Line Items]          
Net sales $ 596,328 [1] $ 579,315 [2] $ 1,579,113 [3] $ 1,585,674 [4]  
Segment operating income (loss) 10,344 10,951 (30,702) (21,738)  
Goodwill impairment 0 0 0 28,453 [5]  
Asset impairments and other 134 [6] 99 [6] 1,490 [7] 581 [8]  
Operating income (loss) 10,210 10,852 (32,192) (50,772)  
Other components of net periodic benefit cost 86 148 281 388  
Interest expense, net 1,213 2,207 3,448 6,241  
Earnings (loss) from continuing operations before income taxes 8,911 8,497 (35,921) (57,401)  
Total assets 1,435,521 [9] 1,492,931 [10] 1,435,521 [9] 1,492,931 [10] $ 1,329,890
Depreciation and amortization 13,054 12,330 39,460 35,449  
Capital expenditures 13,123 14,440 27,397 49,738  
Journeys Group          
Segment Reporting Information [Line Items]          
Net sales 362,517 [1] 349,367 [2] 920,808 [3] 908,832 [4]  
Schuh Group          
Segment Reporting Information [Line Items]          
Net sales 121,826 [1] 118,129 [2] 338,736 [3] 334,033 [4]  
Johnston & Murphy Group          
Segment Reporting Information [Line Items]          
Net sales 78,463 [1] 81,411 [2] 228,707 [3] 241,823 [4]  
Genesco Brands Group          
Segment Reporting Information [Line Items]          
Net sales 33,522 [1] 30,408 [2] 90,862 [3] 100,986 [4]  
Goodwill impairment       28,500  
Operating Segments          
Segment Reporting Information [Line Items]          
Net sales 596,393 581,817 1,577,192 1,588,929  
Operating Segments | Journeys Group          
Segment Reporting Information [Line Items]          
Net sales 362,517 349,367 920,808 908,832  
Segment operating income (loss) 13,166 11,975 (16,807) (21,265)  
Goodwill impairment [5]       0  
Asset impairments and other 0 [6] 0 [11] 0 [7] 0 [8]  
Operating income (loss) 13,166 11,975 (16,807) (21,265)  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Earnings (loss) from continuing operations before income taxes 13,166 11,975 (16,807) (21,265)  
Total assets 746,432 [9] 798,968 [10] 746,432 [9] 798,968 [10]  
Depreciation and amortization 8,385 8,078 25,545 23,235  
Capital expenditures 6,255 8,235 14,059 32,447  
Operating Segments | Schuh Group          
Segment Reporting Information [Line Items]          
Net sales 121,826 118,129 338,736 334,033  
Segment operating income (loss) 3,119 5,484 4,562 12,110  
Goodwill impairment [5]       0  
Asset impairments and other 0 [6] 0 [6] 0 [7] 0 [8]  
Operating income (loss) 3,119 5,484 4,562 12,110  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Earnings (loss) from continuing operations before income taxes 3,119 5,484 4,562 12,110  
Total assets 215,531 [9] 213,036 [10] 215,531 [9] 213,036 [10]  
Depreciation and amortization 1,944 1,566 5,662 4,751  
Capital expenditures 3,109 3,380 5,606 9,376  
Operating Segments | Johnston & Murphy Group          
Segment Reporting Information [Line Items]          
Net sales 78,463 81,414 228,707 241,832  
Segment operating income (loss) (91) 2,706 1,861 10,178  
Goodwill impairment [5]       0  
Asset impairments and other 0 [6] 0 [6] 0 [7] 0 [8]  
Operating income (loss) (91) 2,706 1,861 10,178  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Earnings (loss) from continuing operations before income taxes (91) 2,706 1,861 10,178  
Total assets 178,166 [9] 185,179 [10] 178,166 [9] 185,179 [10]  
Depreciation and amortization 1,358 1,365 4,136 3,622  
Capital expenditures 3,561 1,975 6,737 5,277  
Operating Segments | Genesco Brands Group          
Segment Reporting Information [Line Items]          
Net sales 33,587 32,907 88,941 104,232  
Segment operating income (loss) 3,729 (1,560) 5,415 259  
Goodwill impairment [5]       0  
Asset impairments and other 0 [6] 0 [6] 0 [7] 0 [8]  
Operating income (loss) 3,729 (1,560) 5,415 259  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Earnings (loss) from continuing operations before income taxes 3,729 (1,560) 5,415 259  
Total assets 69,478 [9] 52,170 [10] 69,478 [9] 52,170 [10]  
Depreciation and amortization 337 265 982 669  
Capital expenditures 108 710 643 1,788  
Corporate & Other          
Segment Reporting Information [Line Items]          
Net sales 0 [1] 0 [2] 0 [3],[12] 0 [4]  
Segment operating income (loss) (9,579) (7,654) (25,733) (23,020)  
Goodwill impairment [5]       28,453  
Asset impairments and other 134 [6] 99 [6] 1,490 [7] 581 [8]  
Operating income (loss) (9,713) (7,753) (27,223) (52,054)  
Other components of net periodic benefit cost 86 148 281 388  
Interest expense, net 1,213 2,207 3,448 6,241  
Earnings (loss) from continuing operations before income taxes (11,012) (10,108) (30,952) (58,683)  
Total assets 225,914 [9] 243,578 [10] 225,914 [9] 243,578 [10]  
Depreciation and amortization 1,030 1,056 3,135 3,172  
Capital expenditures 90 140 352 850  
Intercompany Sales Elimination          
Segment Reporting Information [Line Items]          
Net sales (65) (2,502) 1,921 [12] (3,255)  
Intercompany Sales Elimination | Journeys Group          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 [12] 0  
Intercompany Sales Elimination | Schuh Group          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 [12] 0  
Intercompany Sales Elimination | Johnston & Murphy Group          
Segment Reporting Information [Line Items]          
Net sales 0 (3) 0 [12] (9)  
Intercompany Sales Elimination | Genesco Brands Group          
Segment Reporting Information [Line Items]          
Net sales $ (65) $ (2,499) $ 1,921 [12] $ (3,246)  
[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2025
[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales for the third quarter of Fiscal 2024.
[3] Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2025.
[4] Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales for the first nine months of Fiscal 2024.
[5] Goodwill impairment of $28.5 million is related to Genesco Brand Group.
[6] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.
[7] Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group and $1.0 million for severance.
[8] Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.
[9] Of our $655.0 million of long-lived assets, $93.7 million and $9.8 million relate to long-lived assets in the U.K. and Canada, respectively.
[10] Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.

Note 8

Business Segment Information, Continued

[11] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group
[12] Intercompany sales for the first nine months of Fiscal 2025 reflect net intercompany returns.